BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY)

9 posts

Biotech NewsCould Alnylam Pharma (ALNY) Be a Smart Long-Term Bet on RNA Therapies?

  • BioTech Health X
  • July 11, 2026
We recently published our article 10 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush.…
0 Shares
0
0
0
0
0
0
0

Biotech News10 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush

  • BioTech Health X
  • July 4, 2026
In this article, we will take a look at the 10 Biotech Stocks That Could Turn Medicine Into…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Alnylam Pharmaceuticals (ALNY) Be a Smart Long-Term Buy in Biotech?

  • BioTech Health X
  • June 21, 2026
We recently published our article Top 10 Healthcare Stocks That Could Turn a $1000 Investment Into Something Bigger.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Healthcare Stocks That Could Turn a $1000 Investment Into Something Bigger

  • BioTech Health X
  • June 21, 2026
In this article, we will take a look at the Top 10 Healthcare Stocks That Could Turn a…
0 Shares
0
0
0
0
0
0
0

Biotech NewsCould Alnylam Pharmaceuticals (ALNY) Be One of the Best Biotech Stocks to Buy and Hold?

  • BioTech Health X
  • May 17, 2026
We recently published our article Top 10 Biotech Stocks That Could Climb as Much as 100%. In this…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Biotech Stocks That Could Climb as Much as 100%

  • BioTech Health X
  • May 17, 2026
In this article, will take a look at the Top 10 Biotech Stocks That Could Climb as Much…
0 Shares
0
0
0
0
0
0
0

Biotech NewsHere’s Why You Should Consider Investing in Alnylam Pharmaceuticals (ALNY)

  • BioTech Health X
  • March 22, 2026
We recently published our article Top 10 Biotech Stocks That Could Explode in 2026. In this piece, we…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Biotech Stocks That Could Explode in 2026

  • BioTech Health X
  • March 22, 2026
In this article, will take a look at the Top 10 Biotech Stocks That Could Explode in 2026.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsAlnylam Pharmaceuticals is a Stock to Buy: Eyes $2.25 Billion in 2025 Revenue

  • BioTech Health X
  • May 26, 2025
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is a trailblazing biopharmaceutical company that has redefined modern medicine by pioneering the development…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • 5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Featured Posts
    • November 11, 2026
    10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 11, 2026
    5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
Recent Posts
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
    • November 6, 2026
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,187)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top